APA (7th ed.) Citation

XL, C., HL, W., GM, W., M, T., C, H., JS, R., . . . JB, S. (2021). CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab. Frontiers in immunology, 12, 794638. https://doi.org/10.3389/fimmu.2021.794638

Chicago Style (17th ed.) Citation

XL, Chang, et al. "CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab." Frontiers in Immunology 12 (2021): 794638. https://doi.org/10.3389/fimmu.2021.794638.

MLA (9th ed.) Citation

XL, Chang, et al. "CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab." Frontiers in Immunology, vol. 12, 2021, p. 794638, https://doi.org/10.3389/fimmu.2021.794638.